On April 30, 2026, Gilead Sciences, Inc. held its annual meeting where stockholders elected nine directors and approved the selection of Ernst & Young LLP as the accounting firm for 2026, along with the amended 2022 Equity Incentive Plan; however, several stockholder proposals were rejected.